Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03989297
What this trial is testing

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Kiang Wu Hospital 104
Not applicableUnknownNCT05682703
What this trial is testing

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaEBV Infection
Nanfang Hospital, Southern Medical University 2,000
Post-approval studies (Phase 4)Study completedNCT00365508
What this trial is testing

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Fox Chase Cancer Center 642
Large-scale testing (Phase 3)Ended earlyNCT02137096
What this trial is testing

Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharynx Carcinoma
University of Florida 1
Large-scale testing (Phase 3)UnknownNCT02621970
What this trial is testing

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 534
Not applicableStudy completedNCT02149641
What this trial is testing

Parotid-sparing IMRT for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal CancersIntensity Modulated Radiotherapy With Chemotherapy
Royal Marsden NHS Foundation Trust 42
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Ended earlyNCT02789189
What this trial is testing

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Who this might be right for
Recurrent and Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableStudy completedNCT03656250
What this trial is testing

Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI

Who this might be right for
Nasopharyngeal Cancer
NYU Langone Health 17
Not applicableLooking for participantsNCT05483374
What this trial is testing

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

Who this might be right for
Head and Neck CancerNasopharynx CancerNasal Cavity and Paranasal Sinus Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13,600
Not applicableUnknownNCT05146050
What this trial is testing

Olfactory Change After Chemo-radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 107
Large-scale testing (Phase 3)Active Not RecruitingNCT06629597
What this trial is testing

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)

Who this might be right for
Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd. 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT05524168
What this trial is testing

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 41
Not applicableStudy completedNCT05581550
What this trial is testing

Somatostatin Receptor Imaging in NPC, EBV Related Cancers

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Related Carcinoma
National Cancer Centre, Singapore 15
Early research (Phase 1)Study completedNCT00431210
What this trial is testing

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Dana-Farber Cancer Institute 28
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT00003200
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Looking for participantsNCT04875611
What this trial is testing

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment

Who this might be right for
Nasopharyngeal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 32
Next Page